Thymosin Alpha 1

Thymosin Alpha 1

$49.00
Skip to product information
Thymosin Alpha 1

Thymosin Alpha 1

$49.00

Thymosin-α1 (Tα1 / Thymalfasin) — 28-Amino-Acid Immune-Signaling Peptide

Thymosin-α1 is a naturally occurring 28-residue peptide generated from prothymosin-α. In research, it’s used to study innate–adaptive immune coordination, dendritic-cell/T-cell activation, and antiviral host-defense signaling. 

Identifiers
  • CAS: 62304-98-7 
  • PubChem CID (Thymalfasin): 16130571 
  • Formula / MW: C129H215N33O55 · ≈ 3,108 Da 
  • Sequence (human): Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH (28 aa) 
  • Origin: N-terminally acetylated fragment of prothymosin-α (PTMA) 
How It Works (Plain English)
  • Tα1 engages innate sensors (reported activity at TLR2/TLR9 on antigen-presenting cells) that help prime adaptive T-cell responses
  • It’s often used to explore Th1-leaning immune balance, antigen presentation, and antiviral gene programs in preclinical systems. 
  • Because it’s a defined peptide, researchers can test dose–response and timing with clean readouts vs. complex biologics.
Why Researchers Use It
  • To study dendritic-cell maturation and T-cell priming in vitro/in vivo models. 
  • To analyze host-defense pathways in viral or bacterial challenge paradigms. 
  • To map innate–adaptive cross-talk with precise peptide exposures. 

Key Studies — What Was Tested, What Changed, Why It Matters

Innate sensors → adaptive activation
  • What was tested: Antigen-presenting cell exposure to Tα1 with downstream T-cell readouts.
  • What changed: Increased markers of APC activation and improved T-cell responses in multiple models. 
  • Why it matters: Helps labs dissect how short peptides can bridge innate and adaptive immunity.
Antiviral & host-defense signaling
  • What was tested: Preclinical and clinical-context literature on Tα1 in viral disease models (e.g., hepatitis; respiratory infections).
  • What changed: Reports of enhanced cell-mediated immunity and improved immune balance; findings vary by model and cohort. 
  • Why it matters: Offers a mechanistic tool for probing antiviral readiness and Th1/Th2 balance in controlled settings.
Translational context (regulatory/overview)
  • What was reviewed: FDA background summary on Tα1 bulk substance chemistry (free base vs salt), formula, and safety testing ranges.
  • Key notes: Confirms CAS 62304-98-7, formula C129H215N33O55, and provides nonclinical exposure ranges; use for research-context only here. 

Potential Research Applications

Innate → Adaptive Mapping

  • APC maturation and antigen-presentation assays
  • Th1/Th2 cytokine panels and T-cell function

Host-Defense Models

  • Antiviral readiness and interferon-linked genes
  • Vaccinology adjuvant-style investigations

Systems Immunology

  • Gene-expression arrays and pathway enrichment
  • Time-course designs for dose/timing effects

Synergistic Peptides (for Study Design)

Selank

  • Why pair: Neuroimmune balancing—useful alongside Tα1’s immune-priming studies.
  • Angle: Cytokine profiles (Th1/Th2) plus behavioral-stress markers.

BPC-157

  • Why pair: Tissue/gut barrier models with inflammatory readouts that complement immune signaling.
  • Angle: Barrier function + cytokine panels in co-culture systems.

TB-500 (Tβ4 fragment)

  • Why pair: Matrix/motility signaling to contrast with immune-centric endpoints.
  • Angle: ECM markers + immune-cell recruitment in repair-biology models.

Design Notes

  • Define timing (pre-, co-, or post-challenge) and dose precisely—immune outputs are time-dependent.
  • Use standardized media/serum lots; cytokine assays are sensitive to background noise.
  • Document peptide salt/form, vehicle, pH, light exposure, and storage.

Known Concerns (Context)

  • Model variability: Outcomes depend on pathogen type, challenge dose, and host model/strain.
  • Assay design: Include both innate and adaptive endpoints to avoid partial interpretations.
  • General: Research use only; not for human consumption or therapeutic use.

Handle under cold, low-light conditions; prepare fresh aliquots and avoid repeat freeze–thaw cycles.

Specifications & Handling

  • Form: Lyophilized powder (lot-coded)
  • Purity: ≥ 99% (HPLC/MS verified)
  • Storage: ≤ −20 °C; protect from light/moisture
  • In solution: Aliquot promptly; avoid repeat freeze–thaw
  • Additives: None unless specified per lot
  • Packaging: Tamper-evident; research-only labeling

Regulatory & Use Notice

Sold for laboratory research use only. Not for human consumption, medical, or veterinary use. No human-use instructions are provided. Buyer is responsible for safe handling and regulatory compliance.

Thymosin-alpha 1 (Tα1, Thymalfasin) Peptide Research | Immune Signaling, APC/T-cell Activation, Antiviral Host Defense

Keywords: Thymosin alpha 1, Thymalfasin, Tα1 peptide, prothymosin-α fragment, TLR2 TLR9 signaling, dendritic cell, T-cell priming, Base Peptides.

You may also like